Micro-Tech (Nanjing) Co., Ltd.

Shanghai Stock Exchange 688029.SS

Micro-Tech (Nanjing) Co., Ltd. Operating Income for the year ending December 31, 2023: USD 78.13 M

Micro-Tech (Nanjing) Co., Ltd. Operating Income is USD 78.13 M for the year ending December 31, 2023, a 48.05% change year over year. Operating income is the profit earned by a company from its normal business operations before interest and taxes are deducted.

Micro-Tech (Nanjing) Co., Ltd. Operating Income for the year ending December 31, 2022 was USD 52.77 M, a -8.68% change year over year.
Micro-Tech (Nanjing) Co., Ltd. Operating Income for the year ending December 31, 2021 was USD 57.79 M, a 33.65% change year over year.
Micro-Tech (Nanjing) Co., Ltd. Operating Income for the year ending December 31, 2020 was USD 43.24 M, a -14.35% change year over year.
Micro-Tech (Nanjing) Co., Ltd. Operating Income for the year ending December 31, 2019 was USD 50.48 M, a 53.83% change year over year.

Key data

Date	Operating Income	EBIT	EBITDA	Net Income

Shanghai Stock Exchange: 688029.SS

Micro-Tech (Nanjing) Co., Ltd.

CEO	Mr. Feng Zhang
IPO Date	July 22, 2019
Location	China
Headquarters	No. 10, Gaoke Third Road
Employees	2,404
Sector	Health Care
Industries Medical Instruments Biotechnology Pharmaceuticals

Description

Micro-Tech (Nanjing) Co., Ltd. manufactures and sells non-vascular stents and disposable biopsy forceps primarily in China, Europe, North America, Oceania, etc. The company offers gastroenterology products, such as biliary (longwire), biliary (shortwire), biopsy, dilation and hemostasis products, EUS, nitinol stents, resection products, retrieval devices, and accessories; and pulmonology products, such as airway stents, biopsy, dilation balloons, cytology brushes, retrieval devices, and accessories. The company also offers OEM/ODM services to companies in the medical devices field. Micro-Tech (Nanjing) Co., Ltd. was founded in 1999 and is based in Nanjing, China.

Key trends

Past 5 years